查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球原位杂交市场研究报告 - 行业分析、规模、份额、增长、趋势及2023年至2030年预测
市场调查报告书
商品编码
1305159

全球原位杂交市场研究报告 - 行业分析、规模、份额、增长、趋势及2023年至2030年预测

Global In Situ Hybridization Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 350 Pages | 商品交期: 最快1-2个工作天内

价格

预计到2030年，全球原位杂交市场需求将从2022年的29亿美元达到82.4亿美元，2023-2030年复合年增长率为13.95%。

原位杂交或ISH是分子生物学和遗传学中用于检测和定位细胞或组织中特定DNA或RNA序列的技术。它包括使用与目标序列互补的标记探针与被研究样本中的核酸结合并杂交。ISH可用于鉴定细胞或组织中特定基因序列的存在与否，以及确定这些序列在细胞或组织中的位置。该技术广泛用于研究基因表达、染色体异常和病毒感染。

市场动态：

个性化医疗的发展取决于准确识别和诊断基因突变和改变的能力。ISH是这一过程的关键工具，它使研究人员和临床医生能够检测细胞或组织中的特定核酸序列，从而为治疗决策提供信息并改善患者预后。随着测序技术的进步和基因数据可用性的不断提高，基因组学领域正在迅速扩大。ISH是研究基因表达和特定基因在基因组中位置的关键工具，使其成为基因组学研究的重要技术。癌症和神经系统疾病等疾病的发病率在全球范围内不断上升。ISH是诊断和治疗慢性疾病的重要工具，使临床医生能够准确识别导致疾病发生和发展的基因突变和改变。用于ISH的新探针和检测方法的开发推动了该领域的创新，使研究人员和临床医生能够以更高的准确性和灵敏度检测更少量的核酸。

研究报告包括波特五力模型、市场吸引力分析和价值链分析。这些工具有助于在全球范围内清晰地了解行业结构并评估竞争吸引力。此外，这些工具还对全球原位杂交市场的各个细分市场进行了全面评估。原位杂交行业的增长和趋势为本研究提供了整体方法。

市场细分：

原位杂交市场报告的这一部分提供了国家和地区层面细分市场的详细数据，从而帮助战略家确定各自产品或服务的目标人群以及即将到来的机会。

按技术分类

  • 荧光原位杂交（FISH）
  • 原位变色杂交（CISH）

按探针

  • DNA探针
  • RNA

按产品

  • 仪器
  • 试剂盒和探针
  • 软件
  • 服务

按应用

  • 癌症
  • 细胞遗传学
  • 发育生物学
  • 传染病
  • 其他

按终端用户分类

  • 研究和诊断实验室
  • CRO
  • 学术机构
  • 其他

区域分析

本部分涵盖了区域前景，突出了北美、欧洲、亚太、拉美以及中东和非洲地区对原位杂交市场的当前和未来需求。此外，报告还重点分析了所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况以及全球竞争格局的深入分析。原位杂交市场的主要参与者包括Thermo Fisher Scientific Inc.、Abbott (Abbott Molecular)、PerkinElmer Inc.、BioView、Agilent Technologies Inc.、Merck KGaA、Bio-Rad Laboratories Inc.、Oxford Gene Technology IP Limited、Leica Biosystems Nussloch GmbH、F. Hoffman-La Roche Limited、NeoGenomics Laboratories Inc.和Advanced Cell Diagnostics Inc.。本节包括竞争格局的整体观点，其中包括各种战略发展，如关键并购、未来能力、合作伙伴关系、财务概况、合作、新产品开发、新产品上市和其他发展。

目 录

第一章：前言

  • 报告描述
    • 报告目标
    • 目标受众
    • 独特销售主张（USP）和产品
  • 研究范围
  • 研究方法
    • 市场调研流程
    • 市场调研方法

第二章：执行摘要

  • 市场亮点
  • 全球市场概况

第三章：原位杂交-行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 行业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按技术分类的市场吸引力分析
    • 按探头市场吸引力分析
    • 按产品市场吸引力分析
    • 市场吸引力分析：按应用
    • 市场吸引力分析：按最终用途
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料制造商列表
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 营销渠道发展趋势

5.COVID-19疫情影响分析

第六章：全球原位杂交市场分析：按技术分类

  • 技术概述
  • 历史和预测数据
  • 按技术分析
  • 荧光原位杂交（FISH）
  • 显色原位杂交（CISH）

第七章 ：全球原位杂交市场分析：按探针分类

  • 探针概述
  • 历史和预测数据
  • 按探针分析
  • DNA探针
  • RNA

第八章：全球原位杂交市场分析：按产品分类

  • 产品概述
  • 历史和预测数据
  • 按产品分析
  • 仪器
  • 试剂盒和探针
  • 软件
  • 服务

第九章：全球原位杂交市场分析：按应用分类

  • 概述：按应用分类
  • 历史和预测数据
  • 分析：按应用
  • 癌症
  • 细胞遗传学
  • 发育生物学
  • 传染病
  • 其他

第10章：全球原位杂交市场分析：按最终用途分类

  • 终端用途概述
  • 历史和预测数据
  • 按最终用途分析
  • 研究与诊断实验室
  • CRO
  • 学术机构
  • 其他

第十一章 ：全球原位杂交市场分析：按地域划分

  • 顶级公司份额分析
  • 公司介绍
  • 北美销售分析
    • 概述，历史和预测销售分析
    • 北美细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区各细分市场销售分析
    • 亚太地区各国销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测销售分析
    • 中东和非洲各细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第十二章 ：原位杂交企业竞争格局

  • 原位杂交市场竞争
  • 伙伴关系/合作/协议
  • 合并与收购
  • 新产品上市
  • 其他发展

第十三章 ：公司概况

  • 公司份额分析
  • 市场集中度
  • Thermo Fisher Scientific Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Abbott (Abbott Molecular)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • PerkinElmer Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • BioView
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Agilent Technologies Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Merck KGaA
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Bio-Rad Laboratories Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Oxford Gene Technology IP Limited
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Leica Biosystems Nussloch GmbH
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • F. Hoffman-La Roche Limited
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • NeoGenomics Laboratories Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Advanced Cell Diagnostics Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展

*注：在公司概况中，财务细节和近期发展取决于可用性，如果是私营公司，则可能不包括在内。

Product Code: VMR112110579

The global demand for In Situ Hybridization Market is presumed to reach the market size of nearly USD 8.24 BN by 2030 from USD 2.9 BN in 2022 with a CAGR of 13.95% under the study period 2023 - 2030.

In Situ Hybridization or ISH is a technique used in molecular biology and genetics to detect and localize specific DNA or RNA sequences in cells or tissues. It involves using labelled probes, which are complementary to the target sequence of interest, to bind and hybridize with the nucleic acids in the sample being studied. ISH can be used to identify the presence or absence of specific genetic sequences in cells or tissues, as well as to determine the location of those sequences within the cell or tissue. This technique is widely used in research to study gene expression, chromosomal abnormalities, and viral infections. 

Market Dynamics:

The development of personalized medicine is dependent on the ability to accurately identify and diagnose genetic mutations and alterations. ISH is a critical tool for this process, enabling researchers and clinicians to detect specific nucleic acid sequences in cells or tissues, which can inform treatment decisions and improve patient outcomes. The field of genomics is rapidly expanding, driven by advances in sequencing technologies and the growing availability of genetic data. ISH is a key tool for studying gene expression and the location of specific genes within the genome, making it an essential technique for genomics research. The prevalence of diseases, such as cancer and neurological disorders, is increasing globally. ISH is a critical tool for diagnosing and treating chronic diseases, enabling clinicians to accurately identify genetic mutations and alterations that contribute to disease development and progression. The development of new probes and detection methods for ISH is driving innovation in the field, enabling researchers and clinicians to detect smaller quantities of nucleic acids with higher accuracy and sensitivity. 

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in situ hybridization. The growth and trends of in situ hybridization industry provide a holistic approach to this study. 

Market Segmentation:

This section of the in situ hybridization market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Technology

  • Fluorescent In Situ Hybridization (FISH)
  • Chromogenic In Situ Hybridization (CISH)

By Probe

  • DNA
  • RNA

By Product

  • Instruments
  • Kits & Probes
  • Software
  • Services

By Application

  • Cancer
  • Cytogenetics
  • Developmental Biology
  • Infectious Diseases
  • Others

By End-Use

  • Research & Diagnostic Laboratories
  • CROs
  • Academic Institutes
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the In Situ Hybridization market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the in situ hybridization market include Thermo Fisher Scientific Inc., Abbott (Abbott Molecular), PerkinElmer Inc., BioView, Agilent Technologies Inc., Merck KGaA, Bio-Rad Laboratories Inc., Oxford Gene Technology IP Limited, Leica Biosystems Nussloch GmbH, F. Hoffman-La Roche Limited, NeoGenomics Laboratories Inc., Advanced Cell Diagnostics Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . IN SITU HYBRIDIZATION - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Technology
    • 3.7.2 Market Attractiveness Analysis By Probe
    • 3.7.3 Market Attractiveness Analysis By Product
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By End-use
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5.  IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY TECHNOLOGY

  • 6.1 Overview by Technology
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Technology
  • 6.4 Fluorescent In Situ Hybridization (FISH) Historic and Forecast Sales by Regions
  • 6.5 Chromogenic In Situ Hybridization (CISH) Historic and Forecast Sales by Regions

7 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY PROBE

  • 7.1 Overview by Probe
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Probe
  • 7.4 DNA Historic and Forecast Sales by Regions
  • 7.5 RNA Historic and Forecast Sales by Regions

8 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY PRODUCT

  • 8.1 Overview by Product
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Product
  • 8.4 Instruments Historic and Forecast Sales by Regions
  • 8.5 Kits & Probes Historic and Forecast Sales by Regions
  • 8.6 Software Historic and Forecast Sales by Regions
  • 8.7 Services Historic and Forecast Sales by Regions

9 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY APPLICATION

  • 9.1 Overview by Application
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Application
  • 9.4 Cancer Historic and Forecast Sales by Regions
  • 9.5 Cytogenetics Historic and Forecast Sales by Regions
  • 9.6 Developmental Biology Historic and Forecast Sales by Regions
  • 9.7 Infectious Diseases Historic and Forecast Sales by Regions
  • 9.8 Others Historic and Forecast Sales by Regions

10 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY END-USE

  • 10.1 Overview by End-use
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by End-use
  • 10.4 Research & Diagnostic Laboratories Historic and Forecast Sales by Regions
  • 10.5 CROs Historic and Forecast Sales by Regions
  • 10.6 Academic Institutes Historic and Forecast Sales by Regions
  • 10.7 Others Historic and Forecast Sales by Regions

11 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top  Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE IN SITU HYBRIDIZATION COMPANIES

  • 12.1. In Situ Hybridization Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF IN SITU HYBRIDIZATION INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Thermo Fisher Scientific Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. Abbott (Abbott Molecular)
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. PerkinElmer Inc.
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. BioView
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. Agilent Technologies Inc.
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Merck KGaA
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Bio-Rad Laboratories Inc.
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. Oxford Gene Technology IP Limited
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Leica Biosystems Nussloch GmbH
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. F. Hoffman-La Roche Limited
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. NeoGenomics Laboratories Inc.
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. Advanced Cell Diagnostics Inc.
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments

 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  Analysis by Technology (USD MN)
  •  Fluorescent In Situ Hybridization (FISH) Market Sales by Geography (USD MN)
  •  Chromogenic In Situ Hybridization (CISH) Market Sales by Geography (USD MN)
  •  Analysis Market by Probe (USD MN)
  •  DNA Market Sales by Geography (USD MN)
  •  RNA Market Sales by Geography (USD MN)
  •  Analysis by Product (USD MN)
  •  Instruments Market Sales by Geography (USD MN)
  •  Kits & Probes Market Sales by Geography (USD MN)
  •  Software Market Sales by Geography (USD MN)
  •  Services Market Sales by Geography (USD MN)
  •  Analysis by Application (USD MN)
  •  Cancer Market Sales by Geography (USD MN)
  •  Cytogenetics Market Sales by Geography (USD MN)
  •  Developmental Biology Market Sales by Geography (USD MN)
  •  Infectious Diseases Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Analysis by End-use (USD MN)
  •  Research & Diagnostic Laboratories Market Sales by Geography (USD MN)
  •  CROs Market Sales by Geography (USD MN)
  •  Academic Institutes Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global In Situ Hybridization Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition

LIST OF FIGURES

  •  Research Scope of In Situ Hybridization Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global In Situ Hybridization Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Technology
  •  Market Attractiveness Analysis by Probe
  •  Market Attractiveness Analysis by Product
  •  Market Attractiveness Analysis by Application
  •  Market Attractiveness Analysis by End-use
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Technology (USD MN)
  •  Fluorescent In Situ Hybridization (FISH) Market Sales by Geography (USD MN)
  •  Chromogenic In Situ Hybridization (CISH) Market Sales by Geography (USD MN)
  •  Global Market Analysis by Probe (USD MN)
  •  DNA Market Sales by Geography (USD MN)
  •  RNA Market Sales by Geography (USD MN)
  •  Global Market Analysis by Product (USD MN)
  •  Instruments Market Sales by Geography (USD MN)
  •  Kits & Probes Market Sales by Geography (USD MN)
  •  Software Market Sales by Geography (USD MN)
  •  Services Market Sales by Geography (USD MN)
  •  Global Market Analysis by Application (USD MN)
  •  Cancer Market Sales by Geography (USD MN)
  •  Cytogenetics Market Sales by Geography (USD MN)
  •  Developmental Biology Market Sales by Geography (USD MN)
  •  Infectious Diseases Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market Analysis by End-use (USD MN)
  •  Research & Diagnostic Laboratories Market Sales by Geography (USD MN)
  •  CROs Market Sales by Geography (USD MN)
  •  Academic Institutes Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top  Company Share Analysis

 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.